Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2017-2028

2.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Cancer Immunotherapy Drug Discovery Outsourcing Segment by Type

2.2.1 Type I

2.2.2 Type II

2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type

2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2022)

2.4 Cancer Immunotherapy Drug Discovery Outsourcing Segment by Application

2.4.1 Lung

2.4.2 Breast

2.4.3 Colorectal

2.4.4 Melanoma

2.4.5 Prostate

2.4.6 Head and Neck

2.4.7 Ovarian

2.4.8 Pancreatic

2.5 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application

2.5.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2022)

3 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Player

3.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Players

3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2020-2022)

3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2020-2022)

3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cancer Immunotherapy Drug Discovery Outsourcing by Regions

4.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions (2017-2022)

4.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth (2017-2022)

4.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth (2017-2022)

4.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth (2017-2022)

4.5 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth (2017-2022)

5 Americas

5.1 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)

5.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)

5.3 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2017-2022)

6.2 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)

6.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing by Country (2017-2022)

7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)

7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing by Region (2017-2022)

8.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)

8.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Regions (2023-2028)

10.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Regions (2023-2028)

10.1.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Forecast

10.1.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Forecast

10.1.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Forecast

10.1.5 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Forecast

10.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Country (2023-2028)

10.2.1 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.2.2 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.2.3 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.2.4 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Region (2023-2028)

10.3.1 China Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.3.2 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.3.3 Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.3.4 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.3.5 India Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.3.6 Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Country (2023-2028)

10.4.1 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.4.2 France Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.4.3 UK Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.4.4 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.4.5 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.5 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Region (2023-2028)

10.5.1 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.5.2 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.5.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.5.4 Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.5.5 GCC Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast

10.6 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Type (2023-2028)

10.7 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Aquila BioMedical

11.1.1 Aquila BioMedical Company Information

11.1.2 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Aquila BioMedical Main Business Overview

11.1.5 Aquila BioMedical Latest Developments

11.2 BPS Bioscience, Inc.

11.2.1 BPS Bioscience, Inc. Company Information

11.2.2 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 BPS Bioscience, Inc. Main Business Overview

11.2.5 BPS Bioscience, Inc. Latest Developments

11.3 Celentyx Ltd

11.3.1 Celentyx Ltd Company Information

11.3.2 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Celentyx Ltd Main Business Overview

11.3.5 Celentyx Ltd Latest Developments

11.4 Crown Bioscience, Inc.

11.4.1 Crown Bioscience, Inc. Company Information

11.4.2 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Crown Bioscience, Inc. Main Business Overview

11.4.5 Crown Bioscience, Inc. Latest Developments

11.5 DiscoverX Corporation

11.5.1 DiscoverX Corporation Company Information

11.5.2 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 DiscoverX Corporation Main Business Overview

11.5.5 DiscoverX Corporation Latest Developments

11.6 Explicyte

11.6.1 Explicyte Company Information

11.6.2 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Explicyte Main Business Overview

11.6.5 Explicyte Latest Developments

11.7 Genscript Biotech Corporation

11.7.1 Genscript Biotech Corporation Company Information

11.7.2 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Genscript Biotech Corporation Main Business Overview

11.7.5 Genscript Biotech Corporation Latest Developments

11.8 HD Biosciences Co.

11.8.1 HD Biosciences Co. Company Information

11.8.2 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 HD Biosciences Co. Main Business Overview

11.8.5 HD Biosciences Co. Latest Developments

11.9 Horizon Discovery Group PLC

11.9.1 Horizon Discovery Group PLC Company Information

11.9.2 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Horizon Discovery Group PLC Main Business Overview

11.9.5 Horizon Discovery Group PLC Latest Developments

11.10 ImmunXperts SA

11.10.1 ImmunXperts SA Company Information

11.10.2 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 ImmunXperts SA Main Business Overview

11.10.5 ImmunXperts SA Latest Developments

11.11 Molecular Imaging, Inc.

11.11.1 Molecular Imaging, Inc. Company Information

11.11.2 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Molecular Imaging, Inc. Main Business Overview

11.11.5 Molecular Imaging, Inc. Latest Developments

11.12 Promega Corporation,Personalis, Inc.

11.12.1 Promega Corporation,Personalis, Inc. Company Information

11.12.2 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Promega Corporation,Personalis, Inc. Main Business Overview

11.12.5 Promega Corporation,Personalis, Inc. Latest Developments

11.13 STC Biologics

11.13.1 STC Biologics Company Information

11.13.2 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 STC Biologics Main Business Overview

11.13.5 STC Biologics Latest Developments

12 Research Findings and Conclusion

Table 1. Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Type I

Table 3. Major Players of Type II

Table 4. Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2022)

Table 7. Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2022)

Table 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Player (2020-2022)

Table 12. Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Products Offered

Table 13. Cancer Immunotherapy Drug Discovery Outsourcing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Regions (2017-2022)

Table 18. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Country (2017-2022)

Table 20. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2022)

Table 22. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2022)

Table 24. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Region (2017-2022)

Table 26. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2022)

Table 28. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2022)

Table 30. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Country (2017-2022)

Table 32. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2022)

Table 34. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Cancer Immunotherapy Drug Discovery Outsourcing

Table 43. Key Market Challenges & Risks of Cancer Immunotherapy Drug Discovery Outsourcing

Table 44. Key Industry Trends of Cancer Immunotherapy Drug Discovery Outsourcing

Table 45. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share Forecast by Application (2023-2028)

Table 51. Aquila BioMedical Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 52. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 53. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Aquila BioMedical Main Business

Table 55. Aquila BioMedical Latest Developments

Table 56. BPS Bioscience, Inc. Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 57. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 58. BPS Bioscience, Inc. Main Business

Table 59. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. BPS Bioscience, Inc. Latest Developments

Table 61. Celentyx Ltd Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 62. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 63. Celentyx Ltd Main Business

Table 64. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Celentyx Ltd Latest Developments

Table 66. Crown Bioscience, Inc. Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 67. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 68. Crown Bioscience, Inc. Main Business

Table 69. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Crown Bioscience, Inc. Latest Developments

Table 71. DiscoverX Corporation Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 72. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 73. DiscoverX Corporation Main Business

Table 74. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. DiscoverX Corporation Latest Developments

Table 76. Explicyte Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 77. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 78. Explicyte Main Business

Table 79. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Explicyte Latest Developments

Table 81. Genscript Biotech Corporation Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 82. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 83. Genscript Biotech Corporation Main Business

Table 84. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Genscript Biotech Corporation Latest Developments

Table 86. HD Biosciences Co. Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 87. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 88. HD Biosciences Co. Main Business

Table 89. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. HD Biosciences Co. Latest Developments

Table 91. Horizon Discovery Group PLC Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 92. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 93. Horizon Discovery Group PLC Main Business

Table 94. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Horizon Discovery Group PLC Latest Developments

Table 96. ImmunXperts SA Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 97. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 98. ImmunXperts SA Main Business

Table 99. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. ImmunXperts SA Latest Developments

Table 101. Molecular Imaging, Inc. Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 102. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 103. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Molecular Imaging, Inc. Main Business

Table 105. Molecular Imaging, Inc. Latest Developments

Table 106. Promega Corporation,Personalis, Inc. Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 107. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 108. Promega Corporation,Personalis, Inc. Main Business

Table 109. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Promega Corporation,Personalis, Inc. Latest Developments

Table 111. STC Biologics Details, Company Type, Cancer Immunotherapy Drug Discovery Outsourcing Area Served and Its Competitors

Table 112. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product Offered

Table 113. STC Biologics Main Business

Table 114. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. STC Biologics Latest Developments

List of Figures

Figure 1. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type in 2021

Figure 7. Cancer Immunotherapy Drug Discovery Outsourcing in Lung

Figure 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Lung (2017-2022) & ($ Millions)

Figure 9. Cancer Immunotherapy Drug Discovery Outsourcing in Breast

Figure 10. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Breast (2017-2022) & ($ Millions)

Figure 11. Cancer Immunotherapy Drug Discovery Outsourcing in Colorectal

Figure 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Colorectal (2017-2022) & ($ Millions)

Figure 13. Cancer Immunotherapy Drug Discovery Outsourcing in Melanoma

Figure 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Melanoma (2017-2022) & ($ Millions)

Figure 15. Cancer Immunotherapy Drug Discovery Outsourcing in Prostate

Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Prostate (2017-2022) & ($ Millions)

Figure 17. Cancer Immunotherapy Drug Discovery Outsourcing in Head and Neck

Figure 18. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Head and Neck (2017-2022) & ($ Millions)

Figure 19. Cancer Immunotherapy Drug Discovery Outsourcing in Ovarian

Figure 20. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Ovarian (2017-2022) & ($ Millions)

Figure 21. Cancer Immunotherapy Drug Discovery Outsourcing in Pancreatic

Figure 22. Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Pancreatic (2017-2022) & ($ Millions)

Figure 23. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application in 2021

Figure 24. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Player in 2021

Figure 25. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Regions (2017-2022)

Figure 26. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2017-2022 ($ Millions)

Figure 27. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2017-2022 ($ Millions)

Figure 28. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2017-2022 ($ Millions)

Figure 29. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2017-2022 ($ Millions)

Figure 30. Americas Cancer Immunotherapy Drug Discovery Outsourcing Value Market Share by Country in 2021

Figure 31. Americas Cancer Immunotherapy Drug Discovery Outsourcing Consumption Market Share by Type in 2021

Figure 32. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application in 2021

Figure 33. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 34. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 35. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 36. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 37. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Region in 2021

Figure 38. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application in 2021

Figure 39. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 40. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 41. Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 42. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 43. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 44. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 45. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Country in 2021

Figure 46. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type in 2021

Figure 47. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application in 2021

Figure 48. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 49. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 50. UK Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 51. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 52. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 53. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Region in 2021

Figure 54. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type in 2021

Figure 55. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application in 2021

Figure 56. Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 57. South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 58. Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 59. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth 2017-2022 ($ Millions)

Figure 61. Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 62. APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 63. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 64. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 65. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 66. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 67. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 68. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 69. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 70. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 71. Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 72. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 73. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 74. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 75. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 76. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 77. UK Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 78. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 79. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 80. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 81. Egypt Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 82. South Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 83. Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 84. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)

Figure 85. GCC Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2023-2028 ($ Millions)